恩赛因 2024年度报告

Dear Fellow Shareholder: 2024 was another outstanding year. Our local teams have once again posted impressive clinical and financial results andcontinue to build remarkable momentum in each market across our portfolio. Our success is entirely due to the efforts andcommitment of our local leadership teams, caregivers, field resources and service center partners. One of our most importantpriorities is to support those that care for our patients every day. That core value of “customer second” is something ourteams across the organization embrace as we attract and develop caregivers and leaders. We are building a formidable bullpenof caring and passionate partners who are determined to live our mission to dignify post-acute care. After another record year,we are excited about the many opportunities to continue to grow this effort by capturing the enormous upside in our portfolioas we relentlessly focus on the fundamentals across the organization. Due to these efforts, our GAAP diluted earnings per share for the year was $5.12 and adjusted diluted earnings per share forthe year was $5.50, an increase of 15.3%. In addition, our consolidated GAAP and adjusted revenues for the year were $4.26billion, an increase of 14.2% over the prior year. Lastly our GAAP net income was $298.0 million for the year and our adjustednet income for the year was $320.5 million, an increase of 17.2% over the prior year. We were pleased to see same store occupancy increased to 81.3% during the year ended December 31, 2024. We were alsopleased to see continued strength in our skilled mix throughout the year. We are encouraged by the continued strength in ourskilled mix as it demonstrates the continuously increasing demand for skilled post-acute services. We continued to add to our growing portfolio and are thrilled with the 31 new operations we added during 2024 and 13 newoperations since. We are excited to add density to one of our newest markets in Tennessee and look forward to deepening ourrelationships in the healthcare community there and building upon the foundation of our strong local leadership. We are alsoeager to see our first operation in Alabama gain strength and look forward to bolstering our presence in that state over time.Also, we recently already announced a new transaction that includes two new states, Alaska, and Oregon. As with Alabama,each of these new states is driven by an Ensign leader and will represent a small initial investment with plans to build overtime. Entering new states is a significant undertaking that, for us, must be driven by a proven Ensign leader who is committedto, and has a connection with, the new geography. In addition, we added new operations in almost all of our existing states, spreading out the growth across many markets.While we will continue to evaluate new states that fit our criteria, we will prioritize growth in our established geographies.And while our rate of growth this year was strong, the distribution of our growth across many markets leaves us withsignificant bandwidth to grow in most of our markets. We still see significant opportunity to continue to add meaningfuldensity in the markets we know best and are making progress on several additions during 2025. We look forward to the upcoming year and are confident that our partners can reach new heights in clinical and financialperformance as they apply our proven locally driven healthcare model. As we evaluate our expanding portfolio, we are veryexcited about the continued growth in occupancies and skilled mix that we experienced last year. There are so manyopportunities in front of us to optimize operational efficiencies and drive occupancy and skilled mix as we continue tosuccessfully unlock value and opportunity in the dozens of recently acquired operations. Our leaders are poised to againshowcase our ability to find, acquire and transition performing and underperforming operations by applying proven Ensignprinciples developed over twenty-five years. Sincerely, Barry R. PortChief Executive Officer Our Independent Operating Entity Locations ■Skilled Nursing Operations - 297■Senior Living Operations - 12■Campus Operations - 31 Our People ~50,000Employees ~38,000Patients* 2024 Select Financial Data All information in the charts below is reflective of Ensign's continuing operations only. 2024 Financial Highlights In thousands except per share data UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549_____________________________ FORM 10-K ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.For the fiscal year ended December 31, 2024.OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.For the transition period fromto. Commission file number: 001-33757 THE ENSIGN GROUP, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware33-0861263(State or Other Jurisdiction of(I.R.S. EmployerIncorporation or Organizatio